Avalon Ventures XI, L.P. is an investment firm that reports beneficial ownership of shares in Janux Therapeutics, Inc. (JANX) under U.S. securities law. It has submitted 1 SEC insider filing since 2024, most recently in October 2024.
Every role Avalon Ventures XI, L.P. has reported on a Form 4, reconstructed from the filings themselves. Reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
Janux Therapeutics, Inc. (JANX)1 filingUpdated Aug 31, 2026
Avalon Ventures XI, L.P. files SEC Form 4 reports at Janux Therapeutics, Inc. (JANX). 1 SEC Form 4 filing on record, dated 18 October 2024. Most recent open-market trade: sold $24.76M of JANX on 18 October 2024. Lifetime open-market sales: $77.47M.
Every recent SEC Form 4 transaction Avalon Ventures XI, L.P. has reported, most recent first.
InsiderAlpha's records for Avalon Ventures XI, L.P. go back to 2024: 1 primary Form 4 filing, an average of 0.3 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Insiders who reported open-market trades in the last 12 months at the companies Avalon Ventures XI, L.P. files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Avalon Ventures XI, L.P. is an investment firm of Janux Therapeutics, Inc. (JANX). InsiderAlpha holds 1 primary Form 4 filing for it, the earliest from 2024, updated as new SEC EDGAR filings are processed.
The only primary Form 4 on record is dated 18 October 2024.
Recorded transactions: 0 open-market purchases and 17 open-market sales ($77.47M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
$JANX Janux Therapeutics, Inc.541.8K shares @ $44.75$24.25M